Bellevue Group Ag Nektar Therapeutics Transaction History

Bellevue Group Ag

$5.98 Billion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$3.04 - $5.14 $42,560 - $71,960	-14,000 Reduced 48.61%	14,800 $47,000
Q2 2022 Aug 11, 2022	SELL	$3.17 - $6.17 $15.2 Million - $29.5 Million	-4,779,601 Reduced 99.4%	28,800 $109,000
Q1 2022 May 13, 2022	BUY	$4.16 - $13.72 $1.48 Million - $4.89 Million	356,708 Added 8.01%	4,808,401 $25.9 Million
Q4 2021 Feb 10, 2022	SELL	$10.83 - $18.41 $1.55 Million - $2.63 Million	-142,963 Reduced 3.11%	4,451,693 $60.1 Million
Q3 2021 Nov 12, 2021	BUY	$13.07 - $18.84 $6.45 Million - $9.29 Million	493,252 Added 12.03%	4,594,656 $82.5 Million
Q2 2021 Aug 12, 2021	BUY	$16.52 - $20.4 $2.43 Million - $2.99 Million	146,800 Added 3.71%	4,101,404 $70.4 Million
Q1 2021 May 12, 2021	BUY	$16.56 - $25.46 $1.46 Million - $2.25 Million	88,346 Added 2.29%	3,954,604 $79.1 Million
Q4 2020 Feb 16, 2021	BUY	$15.77 - $19.03 $3.69 Million - $4.45 Million	233,900 Added 6.44%	3,866,258 $65.7 Million
Q3 2020 Nov 16, 2020	BUY	$16.59 - $24.79 $1.61 Million - $2.41 Million	97,345 Added 2.75%	3,632,358 $60.3 Million
Q2 2020 Aug 13, 2020	BUY	$16.86 - $23.44 $848,058 - $1.18 Million	50,300 Added 1.44%	3,535,013 $81.9 Million
Q1 2020 May 14, 2020	BUY	$14.47 - $27.96 $979,836 - $1.89 Million	67,715 Added 1.98%	3,484,713 $62.2 Million
Q4 2019 Feb 14, 2020	BUY	$15.87 - $23.12 $3.87 Million - $5.64 Million	244,112 Added 7.69%	3,416,998 $73.8 Million
Q3 2019 Nov 14, 2019	BUY	$16.91 - $36.27 $9.13 Million - $19.6 Million	540,200 Added 20.52%	3,172,886 $57.8 Million
Q2 2019 Aug 14, 2019	BUY	$31.0 - $36.3 $68.3 Million - $80 Million	2,202,660 Added 512.22%	2,632,686 $93.7 Million
Q1 2019 May 15, 2019	BUY	$31.58 - $46.35 $5.33 Million - $7.82 Million	168,816 Added 64.63%	430,026 $14.4 Million
Q4 2018 Feb 12, 2019	BUY	$30.43 - $56.65 $6.26 Million - $11.7 Million	205,690 Added 370.48%	261,210 $8.59 Million
Q3 2018 Nov 13, 2018	BUY	$46.46 - $68.49 $976,589 - $1.44 Million	21,020 Added 60.93%	55,520 $3.38 Million
Q2 2018 Aug 07, 2018	SELL	$46.25 - $104.45 $46,250 - $104,450	-1,000 Reduced 2.82%	34,500 $1.69 Million
Q1 2018 May 09, 2018	SELL	$57.4 - $108.44 $2.25 Million - $4.25 Million	-39,200 Reduced 52.48%	35,500 $3.77 Million
Q4 2017 Feb 14, 2018	SELL	$23.02 - $60.5 $1.11 Million - $2.92 Million	-48,300 Reduced 39.27%	74,700 $4.46 Million
Q3 2017 Nov 13, 2017	BUY	$17.79 - $24.0 $1.42 Million - $1.92 Million	80,000 Added 186.05%	123,000 $2.95 Million
Q2 2017 Aug 14, 2017	BUY	N/A	43,000	43,000 $841,000

Others Institutions Holding NKTR

# of Institutions

140

Shares Held

135M

Call Options Held

32.8K

Put Options Held

55.5K

Deep Track Capital, LP Greenwich, CT

17.9M
Shares

$23.2 Million
0.73% of portfolio
Black Rock Inc. New York, NY

15.2M
Shares

$19.7 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13M
Shares

$16.9 Million
0.0% of portfolio
Samlyn Capital, LLC New York, NY

9.46M
Shares

$12.3 Million
0.21% of portfolio
Eventide Asset Management, LLC Boston, MA

7.53M
Shares

$9.79 Million
0.16% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $244M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account